Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Cortexyme, Inc. stock logo
CRTX
Cortexyme
$1.72
-6.0%
$1.59
$1.78
$40.66
$51.86M1.4620,672 shs256,720 shs
Invizyne Technologies Inc. stock logo
IZTC
Invizyne Technologies
$9.99
-0.4%
$10.60
$8.50
$23.00
$62.46MN/A37,647 shs2,415 shs
Cardiff Oncology, Inc. stock logo
TROV
Cardiff Oncology
$2.44
-0.4%
$16.75
$0.70
$3.46
$26.87M1.04648,892 shs975,543 shs
ZIVO Bioscience, Inc. stock logo
ZIVO
ZIVO Bioscience
$18.22
+1.2%
$13.71
$6.50
$22.15
$69.55M-0.061,041 shs1,227 shs
7 Stocks to Ride The A.I. Megaboom Cover


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Cortexyme, Inc. stock logo
CRTX
Cortexyme
-6.01%+3.61%-3.37%+105.01%+212.90%
Invizyne Technologies Inc. stock logo
IZTC
Invizyne Technologies
-0.43%-0.20%+1.82%-26.30%+998,999,900.00%
Cardiff Oncology, Inc. stock logo
TROV
Cardiff Oncology
+0.82%+0.41%-40.68%-10.91%+12.39%
ZIVO Bioscience, Inc. stock logo
ZIVO
ZIVO Bioscience
0.00%+25.74%+37.20%+1.22%+112.44%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Cortexyme, Inc. stock logo
CRTX
Cortexyme
N/AN/AN/AN/AN/AN/AN/AN/A
Invizyne Technologies Inc. stock logo
IZTC
Invizyne Technologies
N/AN/AN/AN/AN/AN/AN/AN/A
Cardiff Oncology, Inc. stock logo
TROV
Cardiff Oncology
N/AN/AN/AN/AN/AN/AN/AN/A
ZIVO Bioscience, Inc. stock logo
ZIVO
ZIVO Bioscience
0.242 of 5 stars
0.03.00.00.00.61.70.0
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Cortexyme, Inc. stock logo
CRTX
Cortexyme
0.00
N/AN/AN/A
Invizyne Technologies Inc. stock logo
IZTC
Invizyne Technologies
0.00
N/AN/AN/A
Cardiff Oncology, Inc. stock logo
TROV
Cardiff Oncology
0.00
N/AN/AN/A
ZIVO Bioscience, Inc. stock logo
ZIVO
ZIVO Bioscience
0.00
N/AN/AN/A
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Cortexyme, Inc. stock logo
CRTX
Cortexyme
N/AN/AN/AN/A$3.97 per shareN/A
Invizyne Technologies Inc. stock logo
IZTC
Invizyne Technologies
N/AN/AN/AN/AN/AN/A
Cardiff Oncology, Inc. stock logo
TROV
Cardiff Oncology
$250K107.47N/AN/A$0.94 per share2.60
ZIVO Bioscience, Inc. stock logo
ZIVO
ZIVO Bioscience
$15.85K4,387.74N/AN/A($0.81) per share-22.49
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Cortexyme, Inc. stock logo
CRTX
Cortexyme
-$89.94M-$2.97N/AN/AN/AN/A-70.96%-63.53%N/A
Invizyne Technologies Inc. stock logo
IZTC
Invizyne Technologies
N/AN/A0.00N/AN/AN/AN/AN/A
Cardiff Oncology, Inc. stock logo
TROV
Cardiff Oncology
-$16.41M-$2.80N/AN/A-3,688.31%-202.00%-122.92%N/A
ZIVO Bioscience, Inc. stock logo
ZIVO
ZIVO Bioscience
-$7.78M-$4.93N/AN/AN/AN/A-2,240.92%N/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Cortexyme, Inc. stock logo
CRTX
Cortexyme
N/AN/AN/AN/AN/A
Invizyne Technologies Inc. stock logo
IZTC
Invizyne Technologies
N/AN/AN/AN/AN/A
Cardiff Oncology, Inc. stock logo
TROV
Cardiff Oncology
N/AN/AN/AN/AN/A
ZIVO Bioscience, Inc. stock logo
ZIVO
ZIVO Bioscience
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Cortexyme, Inc. stock logo
CRTX
Cortexyme
N/A
9.92
9.92
Invizyne Technologies Inc. stock logo
IZTC
Invizyne Technologies
N/AN/AN/A
Cardiff Oncology, Inc. stock logo
TROV
Cardiff Oncology
0.12
2.37
2.37
ZIVO Bioscience, Inc. stock logo
ZIVO
ZIVO Bioscience
N/A
0.17
0.17

Institutional Ownership

CompanyInstitutional Ownership
Cortexyme, Inc. stock logo
CRTX
Cortexyme
63.18%
Invizyne Technologies Inc. stock logo
IZTC
Invizyne Technologies
N/A
Cardiff Oncology, Inc. stock logo
TROV
Cardiff Oncology
9.99%
ZIVO Bioscience, Inc. stock logo
ZIVO
ZIVO Bioscience
12.83%

Insider Ownership

CompanyInsider Ownership
Cortexyme, Inc. stock logo
CRTX
Cortexyme
27.90%
Invizyne Technologies Inc. stock logo
IZTC
Invizyne Technologies
N/A
Cardiff Oncology, Inc. stock logo
TROV
Cardiff Oncology
0.60%
ZIVO Bioscience, Inc. stock logo
ZIVO
ZIVO Bioscience
48.90%
CompanyEmployeesShares OutstandingFree FloatOptionable
Cortexyme, Inc. stock logo
CRTX
Cortexyme
5530.15 million21.74 millionNot Optionable
Invizyne Technologies Inc. stock logo
IZTC
Invizyne Technologies
296.25 millionN/AN/A
Cardiff Oncology, Inc. stock logo
TROV
Cardiff Oncology
N/A11.01 millionN/ANot Optionable
ZIVO Bioscience, Inc. stock logo
ZIVO
ZIVO Bioscience
103.82 million2.91 millionNot Optionable

Recent News About These Companies

Harmony Biosciences Holdings
Regencell Bioscience Holdings Ltd RGC
ZIVO Bioscience Announces Uplisting to OTCQB Market
Ideaya Biosciences
Dare Bioscience Inc DARE
Zivo Bioscience Inc (ZIVO) USD0.001
Zivo Bioscience Inc ZIVO
Zivo Bioscience Announces 1-for-6 Reverse Stock Split To Regain Compliance

New MarketBeat Followers Over Time

Media Sentiment Over Time

Cortexyme stock logo

Cortexyme NASDAQ:CRTX

$1.72 -0.11 (-6.01%)
As of 08/13/2025

Cortexyme, Inc., a clinical stage biopharmaceutical company, focuses on developing therapeutics for Alzheimer's and other degenerative diseases. Its lead drug candidate is atuzaginstat (COR388), an orally administered brain-penetrating small molecule gingipain inhibitor, which is in Phase II/III clinical trial for use in patients with mild to moderate Alzheimer's disease, as well as for the treatment of oral squamous cell carcinoma, periodontitis, and coronavirus infection. The company was incorporated in 2012 and is headquartered in South San Francisco, California.

Invizyne Technologies stock logo

Invizyne Technologies NASDAQ:IZTC

$9.99 -0.04 (-0.43%)
As of 08/13/2025

Invizyne Technologies Inc. is a cell-free enzyme-based biomanufacturing technology company. It redefining biomanufacturing by leveraging cell-free, multi-step, enzyme-based systems to efficiently transform natural or renewable resources into highly sought after biochemicals. Invizyne Technologies Inc. is based in Monrovia, CA.

Cardiff Oncology stock logo

Cardiff Oncology NASDAQ:TROV

Cardiff Oncology, Inc. is an oncology therapeutics company, which engages in the development of drugs that target mitosis for the treatment of various types of cancer. The company was founded by Gabriel M. Cerrone, L. David Tomei, Samuil Umansky, and Hovsep Melkonyan in 1999 and is headquartered in San Diego, CA.

ZIVO Bioscience stock logo

ZIVO Bioscience NASDAQ:ZIVO

$18.22 +0.21 (+1.17%)
As of 08/13/2025 01:13 PM Eastern

ZIVO Bioscience, Inc., a research and development company, engages in licensing and selling natural bioactive ingredients derived from its proprietary algae cultures to animal, human, and dietary supplement and medical food manufacturers. The company operates in the biotech and agtech sectors, with an intellectual property portfolio comprising proprietary algal and bacterial strains, biologically active molecules and complexes, production techniques, cultivation techniques, and patented or patent-pending inventions for applications in human and animal health. Its products indications include poultry gut health, bovine mastitis, canine joint health, human immune modification, algal biomass for human consumption, and biomass for supporting skin health / anti-aging. The company was formerly known as Health Enhancement Products, Inc. and changed its name to ZIVO Bioscience, Inc. in October 2014. ZIVO Bioscience, Inc. is headquartered in Bloomfield Hills, Michigan.